[Cancer, onco-haematological treatment and cardiovascular toxicity]

Abstract

The increased availability of new cancer treatments in recent years has led to improved prognosis and increased life expectancy for cancer patients, but at the expense of increased cardiovascular risk. For this reason, multidisciplinary teams need to be formed for the joint evaluation of these patients to optimise the cardiovascular health and overall survival of these patients and minimise interruptions to onco-haematological treatments. A wide range of cardiovascular toxicities are associated with the various cancer treatments. The structured control of cardiovascular risk before, during and after oncological treatment will enable strategies for the prevention, early detection and early treatment of cardiotoxicities.

Keywords: Cancer; Cardio-onco-haematology; Cardio-onco-hematología; Cardiotoxicidad; Cardiotoxicity; Cardiovascular risk; Cáncer; Onco-haematological treatments; Riesgo cardiovascular; Tratamientos onco-hematológicos.